Fig. 3
From: High baseline Tie1 level predicts poor survival in metastatic breast cancer
Progression-free survivals and overall survivals grouped by baseline plasma Tie1 or Ang2 levels a Progression-free survival for patients with high or low plasma Tie1 at baseline. b Progression-free survival for patients with high or low plasma Ang2 at baseline. c Overall survival for patients with high or low plasma Tie1 at baseline. d Overall survival for patients with high or low plasma Ang2 at baseline. Cox regression analysis adjusted by age, menopausal status, hormone receptor status, presence of visceral metastasis, number of metastatic lesions and extent of the disease